Trial NCT05532163

View at ClinicalTrials.gov 
Org. Study IDs: DE-TYS-12072
Secondary IDs: 2022-001820-14

Last trial update was posted on 2024-04-17

MeSH Interventions

Natalizumab

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions


Stopping Reasons

Sponsor's decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID